BRIEF-Merck says EU Zepatier launch may be delayed

* Says European launch of its new Zepatier hepatitis C drug may may be delayed until late 2016 or 2017 after EU regulator cited inadequate record-keeping by a third party manufacturer Source text for Eikon: Further company coverage: (Reporting by Ransdell Pierson)
Data & News supplied by www.cloudquote.io
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms and Conditions.